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Vpu is a small type 1 integral membrane phosphoprotein
of the human immunodeficiency virus type 1 (HIV-1),
predominantly localized in the endoplasmic reticulum
(ER)/Golgi compartments of infected or vpu-transfected
cells. Although localized in the membrane of the ER, there
is no obvious sequence element identified for its retention
in the ER or its distribution in the Golgi apparatus. In the
present study, we assess the role of the carboxyl-terminal
tetrapeptide sequence, VDDL, and the consensus glyco-
sylation signal sequence, NES, on the subcellular distribu-
tion and localization of the Vpu protein of HIV-1LAI
(subtype B) in HeLa cells. We fused the wild-type Vpu
gene and Vpu genes that carry either the VDDL deletion
(Vpu) and/or a glycosylation site mutation, to the
enhanced green fluorescent protein (EGFP) gene, and
monitored the subcellular distribution of the proteins in
co-localization and fluorescence confocal microscopy
studies. We found that both the EGFP-wtVpu and EGFP-
Vpu proteins co-localized with an ER marker, while a spe-
cies of the EGFP- Vpu protein also co-localized with a
Golgi marker. However, alteration of the putative glyco-
sylation signal in the EGFP- Vpu background resulted in
the accumulation of Vpu in the Golgi. Our results suggest
that the enhanced Golgi accumulation of Vpu proteins
harboring both the VDDL deletion and a point mutation
in NES sequence may have resulted from the removal of a
restriction that would otherwise retain Vpu to the ER com-
partment of the cell. (Supported by RCMI Grant
#5G12RR017581-05 from NCRR-NIH).
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